For this reason, several clinical and epidemiological studies have investigated the involvement of IGF-I in neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and in healthy aging conditions in which a gradual decline in both circulating and brain IGF-I levels has been reported [10]. This evidence concerns the gene IGF1 and neurodegenerative disease.